Morgan Stanley Double Upgrades Novartis (NVS) to Overweight
Tweet Send to a Friend
Morgan Stanley upgraded Novartis (NYSE: NVS) from Underweight to Overweight with SFr 88 price target.Analyst Vincent Meunier said their long-held ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
